Impact of Non-Alcoholic Simple Fatty Liver Disease on Antituberculosis Drug-Induced Liver Injury.

Liu, Yi-Hui; Guo, Yan; Xu, Hong; Feng, Hui; Chen, Dong-Ya

Liu, Yi-Hui; Guo, Yan; Xu, Hong; Feng, Hui; Chen, Dong-Ya.

Afiliação

Liu YH; Department of Digestive Hepatology, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang, 310003, People's Republic of China.
Guo Y; Department of Gastroenterology, Hangzhou Third Hospital, Hangzhou, Zhejiang, 310009, People's Republic of China.
Xu H; Department of Digestive Hepatology, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang, 310003, People's Republic of China.
Feng H; Department of Digestive Hepatology, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang, 310003, People's Republic of China.
Chen DY; Department of Digestive Hepatology, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang, 310003, People's Republic of China.

Infect Drug Resist ; 14: 3667-3671, 2021.

Article em En | MEDLINE | ID: mdl-34526786

Palavras-chave

antituberculosis drugs; drug-induced liver injury; non-alcoholic simple fatty liver disease

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Infect Drug Resist Ano de publicação: 2021 Tipo de documento: Article País de publicação: Nova Zelândia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google